Abstract:2518 Introduction. Neuropilin-2 (NRP-2) is a co-receptor for vascular endothelial growth factor (VEGF) on endothelial cells and increases the binding affinity and activity of the VEGF tyrosine kinase receptors. NRP-2 is overexpressed in pancreatic adenocarcinoma cells relative to normal ductal epithelium; however, the role of NRP-2 on pancreatic cancer tumor cells remains to be elucidated. Methods. NRP-2 expression was reduced with stable short-hairpin RNA (shRNA) transfection. Western blot analyses were done for signaling intermediates. Semi-qiantitative RT-PCR was used to determine VEGF levels. Cellular proliferation was assessed by MTT assay. Migration and invasion studies were carried out in Boyden chambers. Anchorage-independent growth was determined by soft-agar colony formation. In vivo growth was evaluated in a murine subcutaneous xenograft model. Immunohistochemistry was used to quantitate in vivo proliferation and tumor vessel count and morphology. Results. Activation of Akt signaling was reduced in shRNA-NRP-2 clones relative to control clones. ShRNA-NRP-2 cells demonstrated decreased migration, invasion, and anchorage independent growth compared to control cells. In vitro proliferation rates were similar in control- and shRNA-transfected cells. Constitutive expression of the angiogenic mediator Jagged-1 was reduced in shRNA-NRP-2 cells by 57%, whereas VEGF levels were unchanged. Subcutaneous tumors in mice inoculated with shRNA-NRP-2 cells were significantly smaller than control transfected cells by 72-90% (p Conclusion. Reduction of NRP-2 expression in pancreatic cancer cells decreased survival signaling, migration, invasion and ability to grow under anchorage-independent conditions. In vivo , reduction of NRP-2 led to decreased growth of subcutaneous xenograft tumors with increased necrosis and decreased angiogenesis and patent vessels. This study provides evidence for NRP-2 as a potential target on pancreatic adenocarcinoma cells.

NEK2 Phosphorylates RhoGDI1 to Promote Cell Proliferation, Migration and Invasion Through the Activation of RhoA and Rac1 in Colon Cancer Cells

Abstract #1989: Down-regulation of Neuropilin-2 Suppresses in Vivo Growth of Gastric Cancer and Sensitizes Cells to 5Fu-Induced Apoptosis

Neuropilin-2–Mediated Tumor Growth and Angiogenesis in Pancreatic Adenocarcinoma

Neuropilin-2 is Involved in Tumor Growth and Angiogenesis of Pancreatic Adenocarcinoma

Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma

PLK1 phosphorylates RhoGDI1 and promotes cancer cell migration and invasion

NEK2 inactivates the Hippo pathway to advance the proliferation of cervical cancer cells by cooperating with STRIPAK complexes

Role of NEK2 in tumorigenesis and tumor progression

Knockdown of NDRG1 Promote Epithelial-Mesenchymal Transition of Colorectal Cancer Via NF-κB Signaling.

NEK2 Promotes Proliferation, Migration and Tumor Growth of Gastric Cancer Cells Via Regulating KDM5B/H3K4me3.

Knockdown of RhoGDI2 Represses Human Gastric Cancer Cell Proliferation, Invasion and Drug Resistance Via the Rac1/Pak1/LIMK1 Pathway.

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells

Depletion Of Rhogdi2 Expression Inhibits The Ability Of Invasion And Migration In Pancreatic Carcinoma

RhoGDI2 induced malignant phenotypes of pancreatic cancer cells via regulating Snail expression

NEK2 promotes TP53 ubiquitination to enhance the proliferation and migration of TP53 wild-type glioblastoma cells

Centrosomal kinase Nek2 cooperates with oncogenic pathways to promote metastasis

ERK2 Is a Promoter of Cancer Cell Growth and Migration in Colon Adenocarcinoma

NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation

Ndrg1 Regulates Filopodia-Induced Colorectal Cancer Invasiveness Via Modulating Cdc42 Activity

NEK2 Promotes Hepatocellular Carcinoma Migration and Invasion Through Modulation of the Epithelial-Mesenchymal Transition.